HBW Insight is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By


Aker BioMarine ASA


Latest From Aker BioMarine ASA

Wellness Industry Executive Decisions: AHPA's McGuffin Notes 20 Years, Aker Promotes McNeil To Innovation VP, More

AHPA's Michael McGuffin notes accomplishments in 20 years he's led trade group; CbdMD signs former NFL players as brand reps; former British Columbia trade official consults with Naturally Splendid; Canadian cannabis firm Emerald Heath appoints CEO, CCO; and Aker Biomarine promotes McNeil to innovation VP.

Dietary Supplements Appointments

Herbalife Share Repurchase Likely: Health And Wellness Industry News Roundup

$1.45m loan tees up Herbalife share repurchase; Tieraona Low Dog is Vitamin Shoppe's "chief wellnbeing ambassador"; Supplement OWL accepting label input; and more news in brief.

United States Dietary Supplements

Appointments: Shire, Bicycle Therapeutics, Gilead Sciences, Astellas, Alzheon, Alnylam and Amplyx

2017 begins with three Novartis executives finding new roles and high-level appointments made by Shire, Bicycle Therapeutics, Gilead Science and Amplyx Pharmaceuticals.

Appointments BioPharmaceutical

People In Brief: Pfizer, Valeant, Vitalah, Aker, Mulberry Love

Schulman out, Bourla in at Pfizer; Valeant appoints Kellen chairman; Vitalah VP leads Oxylent sales; Aker names Australia head; CRN builds regulatory team; more People In Brief.

Consumer BioPharmaceutical
See All